ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,431.60
-0.04%
Dow Jones
38,589.16
-0.15%
US Dollar vs MXN
18.4648
0.00%
Brent Oil
82.275
0.00%
Bitcoin
66,241.85
0.08%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Kite Pharma, Inc. (KITE)

  7. Kite Pharma, Inc. (KITE) Noticias

KITE

KITE PHARMA, INC. (KITE)

Kite Pharma, Inc.
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:KITE
FechaHoraFuenteTítuloSímboloCompañía
13/10/201716:05Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:KITEKite Pharma, Inc.
05/10/201714:44Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:KITEKite Pharma, Inc.
03/10/201716:12Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:KITEKite Pharma, Inc.
03/10/201715:56Edgar (US Regulatory)Post-effective Amendment to an Automatic Shelf Registration of Form S-3asr or Form F-3asr (posasr)NASDAQ:KITEKite Pharma, Inc.
03/10/201715:44Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:KITEKite Pharma, Inc.
03/10/201708:03Edgar (US Regulatory)(25-NSE)NASDAQ:KITEKite Pharma, Inc.
03/10/201707:46Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:KITEKite Pharma, Inc.
03/10/201707:45Business WireGilead Sciences Completes Acquisition of Kite Pharma, Inc.NASDAQ:KITEKite Pharma, Inc.
03/10/201707:17Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:KITEKite Pharma, Inc.
03/10/201707:00Business WireGilead Sciences Completes Tender Offer for All Outstanding Shares of Kite Pharma, Inc.NASDAQ:KITEKite Pharma, Inc.
26/09/201707:30Business WireGilead Sciences and Kite Pharma Announce Expiration of Hart-Scott-Rodino Waiting PeriodNASDAQ:KITEKite Pharma, Inc.
05/09/201715:13Edgar (US Regulatory)Statement of Ownership: Solicitation (sc 14d9)NASDAQ:KITEKite Pharma, Inc.
05/09/201711:24Edgar (US Regulatory)Tender Offer Statement by Third Party (sc To-t)NASDAQ:KITEKite Pharma, Inc.
01/09/201716:28Edgar (US Regulatory)Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)NASDAQ:KITEKite Pharma, Inc.
01/09/201716:22Edgar (US Regulatory)Written Communication Relating to an Issuer or Third Party (sc To-c)NASDAQ:KITEKite Pharma, Inc.
31/08/201717:23PR Newswire (US)SHAREHOLDER ALERT: Monteverde & Associates PC Announces An Investigation Of Kite Pharma, Inc. - KITENASDAQ:KITEKite Pharma, Inc.
30/08/201711:50Dow Jones NewsFDA Approves First Gene Therapy in U.S. -- UpdateNASDAQ:KITEKite Pharma, Inc.
30/08/201711:25Dow Jones NewsFDA Approves First Gene Therapy in U.S.NASDAQ:KITEKite Pharma, Inc.
29/08/201717:46PR Newswire (US)Harwood Feffer LLP Announces Investigation of Kite Pharma, Inc.NASDAQ:KITEKite Pharma, Inc.
29/08/201702:02Dow Jones NewsGilead Bets $11 Billion On New Cancer Therapy -- WSJNASDAQ:KITEKite Pharma, Inc.
29/08/201702:02Dow Jones NewsWhat's News: Business & Finance -- WSJNASDAQ:KITEKite Pharma, Inc.
28/08/201718:56Dow Jones NewsGilead to Buy Kite Pharma for Roughly $11 Billion -- 2nd UpdateNASDAQ:KITEKite Pharma, Inc.
28/08/201711:26Dow Jones NewsThe Promising New Cancer Treatment Behind Gilead's $11 Billion DealNASDAQ:KITEKite Pharma, Inc.
28/08/201710:55Business WireALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Kite Pharma, Inc.NASDAQ:KITEKite Pharma, Inc.
28/08/201708:29Dow Jones NewsHot Stocks to Watch in the U.S. and CanadaNASDAQ:KITEKite Pharma, Inc.
28/08/201707:46Dow Jones NewsGilead to Buy Kite Pharma for Roughly $11 Billion -- UpdateNASDAQ:KITEKite Pharma, Inc.
28/08/201706:00Business WireGilead Sciences to Acquire Kite Pharma for $11.9 BillionNASDAQ:KITEKite Pharma, Inc.
28/08/201705:59Dow Jones NewsGilead to Buy Kite Pharma for Roughly $11 Billion in CashNASDAQ:KITEKite Pharma, Inc.
17/08/201707:30Business WireKite Highlights Publication from the National Cancer Institute Demonstrating Responses in Patients with Metastatic Solid Tumo...NASDAQ:KITEKite Pharma, Inc.
14/08/201716:10Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:KITEKite Pharma, Inc.
 Showing the most relevant articles for your search:NASDAQ:KITE

Su Consulta Reciente

COIN
SOLUSD
Solana
NYSE
BAC
Bank of America
NYSE
VZ
Verizon Communications
NYSE
KO
Coca Cola
NYSE
AXP
American Express
CCOM
SILVER
SILVER
NASDAQ
AMZN
Amazon.com
NYSE
MRK
Merck
NYSE
DIS
Walt Disney
COIN
BTCUSD
Bitcoin
USOTC
BNPQY
BNP Paribas (QX)
USOTC
DTEGY
Deutsche Telekom (QX)
USOTC
RHHBY
Roche (QX)
FX
EURMXN
Euro vs MXN
NYSE
JPM
JP Morgan Chase
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados